MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
59.73%
Quick Ratio
59.73%
Cash Ratio
55.21%
Debt to Asset Ratio
51.86%
Unit: Thousand (K) dollars
Assets Breakdown
    • Other intangible assets
    • Cash
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Capital redemption reserve
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
7,694
2,768
5,203
2,484
Restricted cash
60
60
60
60
Prepaid expenses
532
731
185
349
Other current assets
38
30
14
53
Total current assets
8,324
3,589
5,462
2,946
Goodwill
-
-
8,430
8,430
Other intangible assets
30,300
30,300
34,000
34,000
Total assets
38,624
33,889
47,892
45,376
Accounts payable
9,401
8,641
8,770
10,844
Accrued expenses
3,513
3,328
2,342
1,623
Convertible notes, net
693
683
673
663
Notes payable, net
-
49
81
198
Notes payable - related party, net
-
-
-
1,256
Warrant liabilities
116
17
61
503
Other current liabilities
212
697
424
481
Total current liabilities
13,935
13,415
12,351
15,568
Derivative liability
-
-
230
100
Other non-current liabilities
-
-
31
69
Deferred tax liability
6,094
6,094
6,952
6,952
Total liabilities
20,029
19,509
19,564
22,689
Authorized 4,365,687,180,943 and 761,963,201,733 ordinary shares at june 30, 2026, and december 31, 2025 issued and outstanding 140,032,769,533 and 90,536,879,533 ordinary shares at june 30, 2026, and december 31, 2025, respectively
1
-
-
6,523
Additional paid-in capital
243,759
234,811
234,318
224,366
Capital redemption reserve
59,342
59,342
59,342
52,194
Accumulated other comprehensive loss
-695
-768
-782
-1,144
Accumulated deficit
-283,812
-279,005
-264,550
-259,252
Total shareholders equity
18,595
14,380
28,328
22,687
Total liabilities and shareholders equity
38,624
33,889
47,892
45,376
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$7,694K (183.81%↑ Y/Y)Prepaid expenses$532K (19.02%↑ Y/Y)Restricted cash$60K (0.00%↑ Y/Y)Other current assets$38K (-54.22%↓ Y/Y)Other intangibleassets$30,300K (-22.66%↓ Y/Y)Total current assets$8,324K (152.17%↑ Y/Y)Total assets$38,624K (-24.13%↓ Y/Y)Total liabilities andshareholders equity$38,624K (-24.13%↓ Y/Y)Total liabilities$20,029K (-20.85%↓ Y/Y)Total shareholdersequity$18,595K (-27.38%↓ Y/Y)Accumulated deficit-$283,812K (-12.24%↓ Y/Y)Accumulated othercomprehensive loss-$695K (37.16%↑ Y/Y)Total currentliabilities$13,935K (-18.69%↓ Y/Y)Deferred tax liability$6,094K (-24.20%↓ Y/Y)Additional paid-in capital$243,759K (10.38%↑ Y/Y)Capital redemptionreserve$59,342K (13.70%↑ Y/Y)Authorized4,365,687,180,943 and...$1K (-99.98%↓ Y/Y)Accounts payable$9,401K (-19.01%↓ Y/Y)Accrued expenses$3,513K (42.34%↑ Y/Y)Convertible notes, net$693K (-1.00%↓ Y/Y)Other currentliabilities$212K (-67.38%↓ Y/Y)Warrant liabilities$116K (-86.61%↓ Y/Y)

Akari Therapeutics Plc (AKTX)

Akari Therapeutics Plc (AKTX)